Immune Checkpoint Inhibitor Therapy Information

Immunotherapy news has been making waves in Taiwan recently. There are many opinions and perspectives on this topic. In a civil society, rational monitoring and discussion is a wonderful thing, and it is through such discourse that systems become more robust.

The following is a brief summary of information on immune checkpoint inhibitor therapy, based on data from (NH)ClinicalTrial.gov as of December 2015.

Symbol Key:

• ◎ Approved for use in Japan
• O Phase 2 or Phase 3 clinical trial in progress or completed in Japan
• ＊ Phase 2 or Phase 3 clinical trial in progress or completed overseas

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Figure 1

Figure 2

Figure 3

Figure 4